recently reported results of a multi-centre retrospective study of 835 patients with metastatic melanoma receiving anti-CTLA-4 or anti-PD-1 therapy with or without previous radiotherapy for unresectable metastases (108). Here, PDCD1 is linked to metastatic melanoma.